Top Markets
#1 Siacoin Siacoin +32.74%
#2 Official Trump Official Trump +23.94%
#3 EXOD EXOD +22.08%
#4 Wrapped STX (Velar) Wrapped STX (Velar) +18.87%
#5 MowCat MowCat +17.75%
#6 Unit Pump Unit Pump +16.97%
#7 Pump.fun Pump.fun +16.97%
#8 Melania Meme Melania Meme +16.48%
#9 Siren Siren +15.35%
#10 Mubarak Mubarak +13.74%
Coin of the day
Siacoin Siacoin
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Annovis Bio, Inc. Annovis Bio, Inc.

Annovis Bio, Inc.

ANVS
Rangering i aksjer #23205
Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on... Annovis Bio, Inc. is a clinical-stage biopharmaceutical company focused on pioneering treatments for neurodegenerative disorders. The firm's flagship drug, Buntanetap, an oral medication, has successfully advanced through Phase 2a clinical trials for Alzheimer's and Parkinson's diseases. This compound is also currently being evaluated in clinical studies for Alzheimer's disease in individuals with Down Syndrome, as well as for various other chronic neurodegenerative conditions. Beyond Buntanetap, Annovis Bio is developing ANVS405 to offer protection against traumatic brain injury and stroke. Additionally, ANVS301 is progressing through Phase I clinical trials, aiming to enhance cognitive capabilities in the later stages of Alzheimer's disease and broader dementia. The company was founded in 2008 and operates out of Berwyn, Pennsylvania.
Aksjekurs
$1.81
Sist synkronisert: 2026-08-21
Markedsverdi
$77.00M
Endring (1 dag)
1.30%
Endring (1 år)
-23.63%
Land
US
Handel Annovis Bio, Inc. (ANVS)

Kategori

Healthcare
Inntekter for Annovis Bio, Inc. (ANVS)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Annovis Bio, Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Annovis Bio, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH